Individualized mRNA Neoantigen Vaccines provoke substantial T cell immunity in Pancreatic Cancer. Individualized mRNA Neoantigen Vaccines provoke substantial T cell immunity in Pancreatic Cancer
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
Phase 1 trial of individualized mRNA vaccine for Pancreatic Cancer. We used scRNA-seq to characterize the phenotype of vaccine associated T cells. Overall design: 5 samples, TCR and GEX
创建时间：
2023-01-02
